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Abstract
It is generally accepted that cognitive processes, such as learning and memory, are affected in depression. The present
study used a rat model of depression, chronic unpredictable mild stress (CUMS), to determine whether hippocampal volume
and neurochemical changes were involved in learning and memory alterations. A further aim was to determine whether
these effects could be ameliorated by escitalopram treatment, as assessed with the non-invasive techniques of structural
magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS). Our results demonstrated that CUMS had
a dramatic influence on spatial cognitive performance in the Morris water maze task, and CUMS reduced the concentration
of neuronal marker N-acetylaspartate (NAA) in the hippocampus. These effects could be significantly reversed by repeated
administration of escitalopram. However, neither chronic stress nor escitalopram treatment influenced hippocampal
volume. Of note, the learning and memory alterations of the rats were associated with right hippocampal NAA
concentration. Our results indicate that in depression, NAA may be a more sensitive measure of cognitive function than
hippocampal volume.
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Introduction
Depression, with 10 to 20% lifetime prevalence, is the most
common psychiatric illness that involves the disturbance of mood
[1]. It is becoming increasingly clear that disturbances in cognitive
processes, especially the impairment of learning and memory
ability, play an important role in the development and
maintenance of depression [2–6]. However, the mechanisms are
not clearly understood.
The hippocampus is a brain structure that has been extensively
studied with regard to stress, depression and the effects of
antidepressants. Previous studies have revealed that the hippo-
campal formation is very susceptible to stress-induced functional
and morphological alterations, including a reduction in the
expression of brain-derived neurotrophic factor (BDNF) [7],
decreases in long-term potentiation [8–9] and inhibition of
neurogenesis in the dentate gyrus (DG) [10]. Accordingly,
functional neuroimaging studies of depressed individuals have
identified abnormalities of resting blood flow and glucose
metabolism in the hippocampus and brain regions that are
extensively connected to it [11]. Additionally, for many years, the
hippocampus has been thought to play a very important role in
encoding, consolidating and processing new information leading to
learning and memory in both animals and humans [12–15]. To
further our understanding of this evidence, it is very important to
investigate whether stress-induced functional and morphological
changes in the hippocampus are correlated with impairments in
learning and memory in depression.
To date, clinical studies have failed to account for depressive
burden, treatment history, age at onset of depression and
heterogeous causes of depression. For this reason, animal studies
are indispensable to improving our understanding of the
neurobiological processes that underlie depression, depression-
cognition interactions, and antidepressant effects. In the present
study, a regimen of chronic unpredictable mild stress (CUMS),
which was initially described by Willner [16] and termed chronic
mild stress (CMS), was used as a reliable experimental model of
depression [17–18]. Most importantly, CUMS has been shown to
mimic daily hassles and stress levels in humans. Thus, this regimen
provides a relatively realistic animal model of anhedonia, a core
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diagnostic and statistical manual of mental disorders IV (DSM-IV)
[19].
Until recently, research has focused on the learning and
memory impairments associated with depression [5,20–21], with
little examination of the relationship between the neurochemical
consequences of CUMS or antidepressant treatment and the
behavioral changes. Magnetic resonance spectroscopy (MRS),
which has become a versatile tool in medicine and pharmacolog-
ical research, is a unique method for non-invasive quantification of
brain metabolites such as N-acetylaspartate (NAA) which plays a
role in myelinisation and neuronal energy metabolism and is
interpreted as a marker of neuron density and function, creatine
and phosphocreatine (Cr) as a measure of cellular energy stores
and usually taken as the internal standard for comparison for its
relative constance, choline-containing compounds (Cho) as a
measure of membrane turnover, myo-inositol (MI) as an astrocyte
marker and glutamate (Glu) as a measure of glutamate metabolism
[22]. Recent technical and methodological developments in high
field and in spectral analysis have dramatically increased the
neurochemical information content achievable from in vivo MRS
spectra [23–24].
In the present study, we aimed to use the non-invasive
techniques of structural magnetic resonance imaging (MRI) and
MRS to investigate whether the hippocampal volume and
neurochemical changes would be related to the learning and
memory changes induced by CUMS or escitalopram treatment in
a rat model of CUMS.
Results
CUMS-induced effects on depressive-like behaviours and
learning and memory are reversed by chronic
escitalopram treatment
At the beginning of the experimental procedure, there were no
significant differences among the groups exposed to the sucrose
preference test [F(3, 20)=0.138, P=0.936] and the forced
swimming test [F(3, 20)=0.159, P=0.694]. After CUMS for 2
weeks, stressed rats (CUMS+saline and CUMS+escitalopram
groups) showed a significant decrease in sucrose preference [F(3,
20)=6.997, P=0.002] and a significant increase in immobility
time [F(3, 20)=13.666, P=0.001]. At the end of the 6th week,
two-way analysis of variance (ANOVA) (CUMS6escitalopram)
revealed significant effects of CUMS [F(1, 22)=32.602,
P=0.000], escitalopram [F(1, 22)=85.595, P=0.000] and a
CUMS6escitalopram interaction [F(2, 21)=31.222, P=0.000] on
the sucrose preference. Post-hoc analysis showed that the sucrose
preference of CUMS+saline animals was significantly decreased
compared with control+saline rats (P,0.05), and this was reversed
by chronic escitalopram administration (P,0.05) (Fig. 1A). There
was no significant difference among groups on total intake of
sucrose and water at the 3 time points (Fig. 1B). In the forced
swimming test, similar effects of CUMS [F(1, 22)=34.315,
P=0.000] and escitalopram [F(1, 22)=30.515, P=0.000] were
demonstrated on the immobility time, with longer immobility in
CUMS+saline (P,0.05, compared with control+saline group) and
a reversal of this effect in CUMS+escitalopram (P,0.05,
compared with CUMS+saline group) (Fig. 1C).
Fig. 2A shows the average escape latency onto a hidden
platform in the acquisition trials of the Morris water maze test,
with progressively shorter latency on consecutive days. Overall,
there was a significant effect of day [F(3, 20)=259.487, P=0.000],
CUMS [F(1, 22)=169.387, P=0.000] and escitalopram [F(1,
22)=112.609, P=0.000] on latency to find the platform. A further
day-by-day analysis revealed that the CUMS+saline group
latencies were significantly longer than the other three groups on
day 2 (P,0.05), day 3 (P,0.01) and day 4 (P,0.01), whereas no
significant difference in swimming velocity was observed among
the different experimental groups.
In the probe trial of the Morris water maze test, CUMS had a
significant effect on crossing times [F(1, 22)=71.176, P=0.000],
but no significant effect on the time in target quadrant [F(1,
22)=3.241, P=0.087], while escitalopram had a significant effect
on both crossing times [F(1, 22)=47.647, P=0.000]and the time in
target quadrant [F(1, 22)=11.688, P=0.003]. Compared with the
control+saline group, CUMS+saline rats displayed fewer crossings
(P,0.05) and less time swimming in the target quadrant (P,0.05).
Escitalopram restored these changes to control levels (Fig. 2B and
2C). During the period of memory retrieval, the swim distance and
swim speed were similar among groups (Fig. 2D and 2E).
CUMS-induced effects on hippocampal volume and
neurochemistry are reversed by chronic escitalopram
treatment
To account for variations in brain size, hippocampal volume was
normalized to intracranial volume (ICV). The normalized hippo-
campal volume of each group was provided as Table 1. Stress and
escitalopram did not influence the volume of hippocampus either in
the left [stress, F(1, 22)=0.027, P=0.871; escitalopram, F(1,
22)=0.096, P=0.760] or the right [stress, F(1, 22)=0.185,
P=0.673; escitalopram, F(1, 22)=0.166, P=0.689] side.
Repeated-measures analysis of variance showed a significant
effect of laterality for NAA/Cr [F(1, 22)=15.633, P=0.001] and
Cho/Cr [F(1, 22)=10.355, P=0.004], and a laterality6stress
interaction for Cho/Cr [F(2, 21)=10.953, P=0.003], as well as a
laterality6stress6drug interaction for NAA/Cr [F(3, 20)=22.020,
P=0.000] and MI/Cr [F(3, 20)=6.115, P=0.022]. Therefore,
separate ANOVA’s in each hemisphere for each metabolite ratio
were undertaken (Table 2). There was a significant effect of stress
on bilateral NAA/Cr [F(1, 22)=4.056, P=0.048 for the right; F(1,
22)=5.617, P=0.028 for the left] and a stress6drug interaction
for right NAA/Cr [F(2, 21)=13.370, P=0.002]. In the right
hippocampus, NAA/Cr was significantly lower in the CUMS+sa-
line group (1.1160.05) compared with the control+saline group
(1.3560.09) (P=0.004). NAA/Cr was significantly increased by
escitalopram treatment, with elevated NAA/Cr in CUMS+esci-
talopram group (1.2960.10) compared with the CUMS+saline
group (P=0.047). In the left hippocampus, there was a decrease of
NAA/Cr in CUMS+saline group (1.1360.05) compared with the
control+saline group (1.1860.09), although this difference was not
significant (P=0.198). As for Cho/Cr, Glu/Cr and MI/Cr,
neither stress nor drug had a significant effect on them.
The relationship between behavioural tests and
hippocampal neurochemistry
Considering that the hippocampal neurochemistry alteration
induced by CUMS and chronic escitalopram treatment was
primarily in NAA/Cr, correlations between behavioural data and
bilateral NAA/Cr were performed. Across all subjects, there was a
significant negative correlation between NAA/Cr of the right
hippocampus and the latency to find the platform in the
acquisition trials of the Morris water maze test on day 1
(r=20.478, P=0.018), day 3 (r=20.539, P=0.007) and day 4
(r=20.450, P=0.027). The correlation of data from day 2
(r=20.348, P=0.096) was not significant (Fig. 3A–D). In
addition, there was a significant positive correlation between
NAA/Cr of the right hippocampus and the crossing number of
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(r=0.627, P=0.001) in the probe trial of the Morris water maze
test (Fig. 3E–F). However, when the 4 groups were examined
separately, the above correlation did not remain significant. In the
left hippocampus, the correlations between NAA/Cr and the
behavioural tests showed a similar trend, although the correlations
did not reach statistical significance. We did not find significant
correlations between right NAA/Cr and most indices of
depression [sucrose preference at week 2 (r=0.187, P=0.382),
immobility time at week 2 (r=20.199, P=0.352) and week 6
(r=20.327, P=0.119)], except for sucrose preference at week 6
(r=0.471, P=0.020). As for the left hippocampus, we found no
significant correlations between NAA/Cr and the indices of
depression mentioned above.
Discussion
In the present study, we demonstrated that CUMS had a
dramatic influence on spatial cognitive performance in the Morris
water maze task, while the repeated administration of escitalopram
significantly ameliorated the cognitive deficits. Furthermore,
CUMS rats exhibited marked reduction of the hippocampus
NAA, whereas administration of escitalopram to stressed rats
prevented such metabolite reductions. However, neither stress nor
escitalopram influenced hippocampus volume. Of note, the
learning and memory alterations of the rats were associated with
right hippocampal NAA.
Many studies have reported memory deficits in depressed
subjects. An effect size analysis of cognitive functioning in 726
patients with major depressive disorder (MDD), conducted using
meta-analytic principles, found that the type of memory task most
affected by depression was recollection [25]. Recollection memory
is analogous to explicit or declarative memory, requiring the
conscious recall of specific facts or events. The present experiments
showed a deficit of spatial memory in rats exposed to chronic
stress, supporting the hypothesis that depressed subjects show
differential impairment on memory tasks that are dependent on
the hippocampus. Our results are consistent with a previous report
Figure 1. Effects of CUMS and escitalopram treatment on sucrose preference (A), sucrose and water total intake (B) and immobility
time in forced swimming test (C) Data are presented as mean ± S.D. (n=6 per group). * P,0.05, ** P,0.01 vs. control+saline group, #
P,0.01 vs. CUMS+saline group.
doi:10.1371/journal.pone.0028686.g001
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chronic stress in mice [26] and the findings of spatial memory
deficits in other animal models of depression [5–6]. Furthermore,
we found a reversal of memory deficits in animals administered the
antidepressant escitalopram. This is consistent with the effects of
psychotherapeutic treatments directed at changing cognitive
processes [27] and is further supported by studies showing that
antidepressant therapy improves cognitive function in both
humans and animals [28–32].
The peak at 2.02 ppm, which emerges as the main peak of the
1H-MRS spectra from the normal brain, is prominently attributable
to NAA, which is synthesised only in neurons of the adult central
nervous system and is commonly considered to be a putative
Figure 2. Effects of CUMS and escitalopram treatment on acquisition and consolidation in the Morris water maze test. (A) In the
acquisition trials, CUMS rats showed longer escape latency during training days 2–4, while escitalopram treatment restored the CUMS-induced longer
latencies to control levels. In the probe trial, CUMS impaired memory retrieval as indicated by fewer crossing times of the platform position (B) and
less time spent in the target quadrant (C), while escitalopram treatment restored the CUMS-induced impairment of memory retrieval to levels seen in
controls. There was no significant difference of swim distance (D) and swim speed (E) among groups. Data are presented as mean 6 S.D. (n=6 per
group). * P,0.05, ** P,0.01 vs. control+saline group. # P,0.05, ##P,0.01, vs. CUMS+saline group.
doi:10.1371/journal.pone.0028686.g002
Table 1. Effects of CUMS and escitalopram treatment on
normalized hippocampal volume.
Laterality CON+saline CON+ESC CUMS+saline CUMS+ESC
Left 30.263.4 29.662.8 29.462.3 30.963.4
Right 28.864.1 26.963.2 28.862.6 27.963.3
To account for variations in brain size, hippocampal volume is expressed
relative to intracranial volume (ICV). The resulting ratios were multiplied by
1000. Data are presented as mean 6 S.D. (n=6 per group). Abbreviations: CON,
control; CUMS, chronic unpredictable mild stress; ESC, escitalopram.
doi:10.1371/journal.pone.0028686.t001
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decrease of NAA resonance in the hippocampus, frontal lobe, and
basal ganglia of depressed subjects [33]. The present study found
significantly decreased NAA in the hippocampus of chronically
stressed animals, suggesting the loss of neuronal integrity in the
hippocampus induced by chronic stress. This finding is similar to
that of Czeh et al. who used a chronic psychosocial stress paradigm
in male tree shrews and found that 1 month of stress could reduce
the concentrations of NAA [34]. The possible mechanisms of
decreased NAA in the hippocampus induced by chronic stress may
involve an elevated glucocorticoid level. It has been shown that
chronic physical or psychological stressors canprovoke the secretion
of glucocorticoid [35]. Numerous observations have demonstrated
that glucocorticoid treatment inhibits neurogenesis in the dentate
gyrus (DG) [10], induces arrest of the neural cell cycle [36] and
apoptosis in neuronal progenitors [37] and initiates dendritic
atrophy, synaptic loss, even cell apoptosis, among hippocampal
neurons [38–40], finally resulting in neuronal dysfunction and loss
as indicated by decreased NAA in hippocampus.
Recently, increasing evidence has indicated that chronic
treatment with SSRIs may reverse the inhibition of neurogenesis
[41] and the impairment of synaptic plasticity and dendritic
arborisation in the hippocampus induced by glucocorticoids [42].
In addition, SSRIs may reverse the delay of the differentiation of
neuronal progenitors into mature neurons [43] as well as protect
against the death of neuronal cells [44] and re-establish granule
cell density of the hippocampus. These findings are consistent with
the effect of a reversal of NAA decrease upon treatment with
escitalopram observed in the present study.
There have been studies showing a relationship between NAA
and memory level in both normal subjects and patients with
neuropsychiatric disorders [45–50]. In keeping with this, our study
demonstrated that the learning and memory alterations of the
animals were associated with hippocampal NAA. This argues that
NAA is a sensitive measure of hippocampal neurons that are
crucial for performance on tasks of memory. In addition, Block et
al. found that clinical response to pharmacological treatment is
associated with an increase in hippocampal NAA in patients with
unipolar major depressive episodes [51]. Consistent with this, our
study demonstrated that, as one component of the response to
treatment, the improvement in learning and memory of the
animals was associated with an increase in hippocampal NAA.
In most neuroimaging studies, regions of interests (ROIs) have
usually beenmanually traced. This method is associated with many
disadvantages including the relatively low objectivity and replicabil-
ity as well as high labour and time intensity. Therefore, we
collaboratively developed a new atlas-based method utilising brain
template and digital atlas to trace the hippocampus automatically
while simultaneously preserving the individual anatomical charac-
teristics [52]. In the present study, we found no hippocampal volume
differences as an effect of CUMS or escitalopram treatment. This is
similar to our negative finding in another animal model of
depression, maternal separation, which simulated early life stress
[53–54]. While several clinical and preclinical studies have reported
diminished volume of the hippocampus in depressed subjects, still
others have reported larger or unchanged hippocampal volume in
depression [11]. This apparent inconsistency may be due to
differences in depressive burden, treatment history, and age at onset
of depression as well as heterogeneity in the causes of depression.
Other studies have reported reduced NAA in the hippocampus of
posttraumatic stress disorder (PTSD) patients in the absence of
hippocampal volume loss [45]. Along with the
1H-MRS findings,
these results suggest that NAA may be a more sensitive measure of
the integrity of the hippocampus than hippocampal volume.
Due to several limitations, the present study must be considered
preliminary. Firstly, it relied on Cr as an internal signal standard,
although Cr changes have been reported in depression in some
studies [33]. Furthermore, even though the position of the VOI
was carefully selected, we were restricted to a cubic voxel by MRI
coil available in order to obtain high signal-to-noise ratios with
limited scan time. Thus, the spatial resolution of
1H-MRS
inevitably included some tissue outside the hippocampus, which
may have introduced spurious metabolite variations. However, the
lack of volume change in the hippocampus rules this out as a
potential contributor to changes in the NAA ratio.
To the best of our knowledge, this is the first animal study
examining the relationship between hippocampal neurochemistry
and learning and memory in depression using non-invasive imaging
technique MRS. These findings raise the possibility that low
hippocampal NAA may be an underlying indicator of increased risk
of learning and memory deficits in depression. Future studies will be
needed to further examine learning and memory correlates of brain
volume and chemistry, using more sensitive measures and moving
beyond the hippocampus to examine additional regions of the brain
that are involved in cognition.
Table 2. Effects of CUMS and escitalopram treatment on hippocampal
1H-MRS measurements.
Laterality Metabolites CON+saline CON+ESC CUMS+saline CUMS+ESC
Left NAA/Cr 1.1860.09 1.2260.08 1.1460.06 1.1360.03
Cho/Cr 0.1660.02 0.1860.02 0.1960.02 0.1860.03
Glu/Cr 1.1760.14 1.1860.26 1.0960.18 0.9460.16
MI/Cr 0.6860.04 0.8060.21 0.6760.10 0.6760.04
Right NAA/Cr 1.3560.09 1.2260.15 1.1160.05** 1.2960.10#
Cho/Cr 0.2060.02 0.2160.04 0.1960.02 0.1860.01
Glu/Cr 1.2960.09 1.1660.22 1.1460.12 1.0960.10
MI/Cr 0.6860.08 0.6560.11 0.6260.05 0.6960.09
Data are presented as mean 6 S.D. (n=6 per group).
**P,0.005 vs. control+saline group,
#P,0.05 vs. CUMS+saline group. Abbreviations: CON, control; CUMS, chronic unpredictable mild stress; ESC, escitalopram; NAA, N-acetylaspartate; Cr, creatine; Cho,
choline-containing compounds; Glu, glutamate; MI, Myo-inositol.
doi:10.1371/journal.pone.0028686.t002
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Animals
Experiments were performed on adult male Sprague–Dawley rats
(AnimalHouseCenter,SoutheastUniversity,China)weighing200 g.
Animals were housed 4 to a cage with food and water available ad
libitum. All rats were kept on a 12 h light–dark cycle (lights on at 7
a.m.) in the same colony room, with constant temperature (2162uC)
and humidity (5565%). All experiments were conducted in
accordance with the National Institutes of Health Guide for the
Care and Use of Laboratory Animals, and the experiments were
approved by Jiang Su Animal Care and Use Committee.
Experimental procedure and drug treatment
Fig. 4 depicts how the experiment was conducted. The rats were
randomly divided into 4 groups: control+saline, control+escitalo-
pram, CUMS+saline and CUMS+escitalopram (n=6 per group).
Two weeks after the beginning of the CUMS regimen, rats
received escitalopram (10 mg/kg, i.p.) or saline treatment once a
day for 4 weeks. A sucrose preference test and a forced swimming
test were administered at 3 time points: before stress (0 week),
before drug administration (2 week) and at the end of the
experiment (6 week). The Morris water maze test and MRI scans
were carried out at the end of the experiment. The same cohort of
animals was used throughout the study.
CUMS procedure
The CUMS procedure contained 9 different stressors randomly
arranged day and night across 42 consecutive days: 20 h food and
water deprivation, 18 h water deprivation, 17 h of 45u cage tilt,
overnight illumination, 21 h wet cage, 5 min swimming in water
at 4uC, 30 min on a 160 Hz rocking bed, 1 min tail pinch and 2 h
Figure 3. Correlation analysis between NAA/Cr of the right hippocampus and the learning and memory test. (A–D) In the acquisition
trials, a significant negative correlation was found between NAA/Cr of right hippocampus and the latency to find platform on day 1 (r=20.478,
P=0.018), day 3 (r=20.539, P=0.007) and day 4 (r=20.450, P=0.027), although the correlation of day 2 (r=20.348, P=0.096) was not significant.
(E) A significant positive correlation was shown between NAA/Cr of right hippocampus and the crossing number of platform (r=0.654, P=0.001). (F)
There is a strong positive correlation between NAA/Cr of right hippocampus and the time spent in the target quadrant (r=0.627, p=0.001).
doi:10.1371/journal.pone.0028686.g003
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by trained and experienced observers who were blind to the
condition of the animals.
Sucrose preference test
In the sucrose preference test, the animals were allowed to
consume water and a 1% sucrose solution for 1 h after 20 h food
and water deprivation, following 48 hours of exposure to both
water and sucrose solution. The positions of the two bottles (right/
left) were varied randomly across animals and were reversed after
30 min. The sucrose preference was calculated according to the
following ratio: sucrose preference (%)=[sucrose intake (g)/
sucrose intake (g)+water intake (g)]6100% [55]. The results reflect
mean values of daily tests over three days.
Forced swim test
For the forced swim test, a method used in previous research
[56] was followed. Briefly, rats were forced to swim individually in
a cylindrical glass container (40 cm height, 30 cm diameter) that
contained tap water (2561uC) of 28 cm depth. Then, 24 h after
pre-swimming for 15 min, rats were subjected to a 5 min
swimming test. All test sessions were recorded with a video
camera from the opposite side of the cylinder. Periods of time
when a rat was passively floating in the water, exerting minimal
activity except respiration, was measured as immobility.
Morris water maze test
The water maze was a black circular pool (160 cm in diameter)
filled with opaque water (30 cm depth) at 2561uC. An escape
platform (11 cm in diameter) was placed in the middle of one of
the quadrants (1 cm below the water surface). The behaviour of
the animal was monitored with a video camera mounted in the
ceiling above the centre of the pool. In the acquisition trials, the
rats were trained for 120 s per trial and 4 trials per day starting at
four different positions with 30 min intervals for 4 consecutive
days. Each trial began with the rat in the pool facing the sidewalls.
If the rat failed to escape within 120 s, it was guided to the
platform by the experimenter. When the rat escaped onto the
platform, the rat was allowed to stay on the platform for 30 s
before being returned to its home cage. The hidden platform was
removed on day 5, and memory retrieval was examined by a
probe trial that lasted for 180 s. The escape latency in the
acquisition trials, the times of crossing the platform position and
the time spent in the target quadrant in the probe test were
recorded by a computerised video tracking system.
MRI and proton MRS (
1H-MRS) acquisition
MRI was undertaken on a 7.0 T animal MRI scanner (70/16
PharmaScan, Bruker Biospin GmbH, Germany) using a 38 mm
birdcage rat brain quadrature resonator for radiofrequency
transmission and reception. Rats were anesthetised using inhaled
isoflurane/O2 (3% for induction and 1.5–2% for maintenance).
During the MRI scan, the rat was prostrated on a custom-made
holder to minimise head motion while respiration was maintained
at a rate of 50 breaths/min.
Scout T2-weighted imaging (T2WI) in three planes with a fast
spin echo (FSE) pulse sequence was first acquired to control rat
head positioning. Next, a coronal T2WI scan was acquired using
rapid-acquisition relaxation-enhancement (RARE) pulse sequence
Figure 4. Schematic representation of animal group assignments and behavioural tests. Rats were randomly divided into 4 groups:
control+saline, control+escitalopram, CUMS+saline and CUMS+escitalopram (n=6 per group). Two weeks after the beginning of the CUMS regimen,
rats received escitalopram (10 mg/kg, i.p.) or saline treatment once a day for another 4 weeks while the CUMS procedure was continued. Sucrose
preference test and forced swimming test were measured before stress (0 week), before drug administration (2 week) and at the end of the
experiment (6 week). Morris water maze and MRI scan were carried out at the end of the experiment.
doi:10.1371/journal.pone.0028686.g004
Figure 5. Illustration of the voxel to the site of hippocampus for
1H-MRS was presented, with associated magnetic resonance
spectrographic imaging spectrum. (A) Left and right hippocampi are indicated by the white rectangles in coronal T2-weighted imaging of rat
brain. (B) Typical hippocampal
1H-MRS with marked Myo-inositol (MI), choline-containing compounds (Cho), creatine and phosphocreatine (Cr),
glutamate (Glu) and N-acetylaspartate (NAA) peaks.
doi:10.1371/journal.pone.0028686.g005
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matrix size=2566256, repetition time (TR)=3500 ms, echo time
(TE)=12 ms, slice thickness=1.0 mm, slice gap=1.5 mm, and
acquisition time=1 min 24 s.
For single-voxel
1H-MRS, the volume of interest (VOI,
3.5 mm63.5 mm63.5 mm) was placed over the hippocampal
region in the coronal T2W images centred approximately at
Bregma 23.8 mm of the standard rat brain atlas (Fig. 5A). Point
resolved spectroscopy (PRESS) sequence was used for signal
acquisition, with TR=2500 ms, TE=20 ms, number of aver-
age=512 and scan durationforeachside=21 min. Inaddition,the
order of acquisition of the right and left hippocampal spectra
alternated between animals scanned, to minimise the introduction
of artifactual hemispheric differences. A typical spectrum is shown
in Fig. 5B.
Hippocampus volume measurements and
1H-MRS
spectral processing
The coronal T2WI data were analysed using statistical
parametric mapping (SPM5). The volume of hippocampus was
extracted using our atlas-based region of interest (ROI) extraction
method that was developed in-house; this extraction method is
based on T2WI rat brain template and digital atlas [52]. To
account for variations in brain size, hippocampal volume was
normalized to intracranial volume (ICV), which was extracted
based on the PCNN (Pulse Coupled Neural Network) method.
The in vivo
1H-MRS were processed using jMRUI software
(version 3.0, http://www.mrui.uab.es/mrui) according to the
methods described by Chan et al [57–58] and our previously
reported paper [53–54]. In short, metabolite peak areas were
determined using the quantum estimation (QUEST) method
combined with a subtraction approach for background modelling
after preconditioning. A simulated basis set was used to estimate
peak areas. To reduce systematic variations between animals, we
applied a relative quantification method using the creatine (Cr)
peak as the internal spectral reference. NAA/Cr, Cho/Cr, Glu/
Cr, and MI/Cr were statistically evaluated.
Statistical analysis
Data were analysed using SPSS software, version 13.0 (SPSS Inc.,
Chicago), and values were presented as mean 6 standard deviation
(S.D.). The results were considered statistically significant if P,0.05.
Two-wayANOVA was applied by the Bonferroni testing as post hoc
analysis for further examination of group differences. Considering
that hippocampal volume and metabolite ratios were measured in
bilateral hippocampi and the acquisition trials of Morris water maze
test were carried out on 4 consecutive days, repeated-measures
analysis of variance was initially performed. Pearson correlations
between the data from the Morris water maze test and hippocampal
volume and metabolite ratios were performed.
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